{{Rsnum
|rsid=7249142
|Gene=MEF2BNB-MEF2B
|Chromosome=19
|position=19165550
|Orientation=plus
|GMAF=0.314
|Gene_s=MEF2B,MEF2BNB-MEF2B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 15.0 | 42.5 | 42.5
| HCB | 6.6 | 34.3 | 59.1
| JPT | 8.0 | 38.9 | 53.1
| YRI | 5.4 | 27.2 | 67.3
| ASW | 7.0 | 38.6 | 54.4
| CHB | 6.6 | 34.3 | 59.1
| CHD | 2.8 | 46.8 | 50.5
| GIH | 10.9 | 34.7 | 54.5
| LWK | 2.7 | 26.4 | 70.9
| MEX | 22.4 | 41.4 | 36.2
| MKK | 2.6 | 34.4 | 63.0
| TSI | 24.5 | 48.0 | 27.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=G
  |Pval=9E-6
  |OR=.15
  |ORtxt=[0.085-0.219] unit increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}